GSK 1018921Alternative Names: 1018921; GSK1018921
Latest Information Update: 29 Mar 2011
At a glance
- Originator GlaxoSmithKline
- Class Antipsychotics
- Mechanism of Action Glycine transporter 1 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Schizophrenia